Hosseini M - Search Results

1

Survival of ovarian cancer in Iran: 2000-2004.

Arab M, Khayamzadeh M, Mohit M, Hosseini M, Anbiaee R, Tabatabaeefar M, Ebrahimi M, Tehranian A, Akbari ME. Arab M, et al. Among authors: hosseini m. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):555-8. Asian Pac J Cancer Prev. 2009. PMID: 19827868 Free article.

2

Crude and age-specific incidence rate patterns for histopathologic subtypes of ovarian cancer in Iran.

Arab M, Khayamzadeh M, Hashemi M, Hosseini M, Tabatabaeefar M, Anbiaee R, Anvari N, Ebrahimi M, Akbari ME. Arab M, et al. Among authors: hosseini m. Arch Iran Med. 2010 May;13(3):203-8. Arch Iran Med. 2010. PMID: 20433224

3

Endometrial cancer in women with abnormal uterine bleeding: Data mining classification methods.

Farzaneh F, Jafari Ashtiani A, Hashemi M, Hosseini MS, Arab M, Ashrafganjoei T, Hooshmand Chayjan S. Farzaneh F, et al. Among authors: hosseini ms. Caspian J Intern Med. 2023 Summer;14(3):526-533. doi: 10.22088/cjim.14.3.526. Caspian J Intern Med. 2023. PMID: 37520874 Free PMC article.

4

Factor XIII deficiency in Iran: a comprehensive review of the literature.

Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, Eshghi P. Dorgalaleh A, et al. Among authors: hosseini s, hosseini ms. Semin Thromb Hemost. 2015 Apr;41(3):323-9. doi: 10.1055/s-0034-1395350. Epub 2015 Jan 23. Semin Thromb Hemost. 2015. PMID: 25615432 Review.

5

Allele frequencies for 15 autosomal STR loci in Fars province population, southwest of Iran.

Hedjazi A, Nikbakht A, Hosseini M, Hoseinzadeh A, Hosseini SM. Hedjazi A, et al. Among authors: hosseini sm, hosseini m. Leg Med (Tokyo). 2013 Jul;15(4):226-8. doi: 10.1016/j.legalmed.2013.01.005. Epub 2013 Mar 9. Leg Med (Tokyo). 2013. PMID: 23477811

6

Red blood cell alloimmunization in Iran: A Comprehensive review of the literature.

Hosseini MS, Jafari L, Shiri Heris R, Gharehbaghian A. Hosseini MS, et al. Asian J Transfus Sci. 2020 Jan-Jun;14(1):4-8. doi: 10.4103/ajts.AJTS_137_17. Epub 2020 Jul 24. Asian J Transfus Sci. 2020. PMID: 33162697 Free PMC article. Review.

7

Therapeutic approaches for relapsed/refractory adult acute lymphoblastic leukemia (ALL), a review on monoclonal antibodies and targeted therapies.

Hosseini MS, Jafari L, Yami A, Gharehbaghian A. Hosseini MS, et al. Indian J Cancer. 2022 Jan-Mar;59(1):4-11. doi: 10.4103/ijc.IJC_567_19. Indian J Cancer. 2022. PMID: 35645049 Free article. Review.

8

Congenital combined deficiency of coagulation factors: a study of seven patients.

Naderi M, Tabibian S, Hosseini MS, Alizadeh S, Hosseini S, Shamsizadeh M, Dorgalaleh A. Naderi M, et al. Among authors: hosseini s, hosseini ms. Blood Coagul Fibrinolysis. 2015 Jan;26(1):59-62. doi: 10.1097/MBC.0000000000000180. Blood Coagul Fibrinolysis. 2015. PMID: 25215615

9

Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.

Naderi M, Ahmadinejad M, Hosseini MS, Moradi E, Dorgalaleh A, Shamsizadeh M. Naderi M, et al. Among authors: hosseini ms. Blood Coagul Fibrinolysis. 2017 Jun;28(4):276-278. doi: 10.1097/MBC.0000000000000578. Blood Coagul Fibrinolysis. 2017. PMID: 27306330

10

Relationship Between Single-Nucleotide Polymorphisms of Tumor Necrosis Factor Alpha, Interleukin-10, Factor II and Factor V with Risk of Inhibitor Development in Patients with Severe Hemophilia A.

Soori S, Dadashizadeh G, Dorgalaleh A, Tabibian S, Keramati MR, Alizadeh S, Hosseini MS, Zaker F, Shams M. Soori S, et al. Among authors: hosseini ms. Cardiovasc Hematol Disord Drug Targets. 2019;19(3):228-232. doi: 10.2174/1871529X19666190206152315. Cardiovasc Hematol Disord Drug Targets. 2019. PMID: 30727925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,446 results

Search Page

Filters